WithdrawnN/Aketamine

Evaluation of Ketamine and Multi-modal Analgesics

Sponsored by University of Florida

NCT ID
NCT02815111
0
Start Date
2016-07
Est. Completion
2018-07

About This Study

The purpose of this research study is to see if pain can be better controlled with fewer side effects. The new drug regimen will study several different medicines that have different ways of treating pain.

Conditions Studied

Pain

Interventions

  • •Ketamine
  • •Lidocaine
  • •Acetaminophen
  • •Neurontin

Eligibility

Age:18 Years - 85 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* American Society of Anesthesiologists (ASA) status 1-4
* Undergoing planned surgery for cardiac problems
* 18 years of age and not older than 85 years of age

Exclusion Criteria:

* Severe liver disease (alanine aminotransferase (ALT) , aspartate aminotransferase (AST), or bilirubin \> 2.5 times Upper Limit of Normal)
* Pregnancy or currently breastfeeding
* History of schizophrenia or other hallucinatory psychiatric disorder
* History of chronic or pre-existing pain disorder
* History of heart block
* Severe renal impairment Creatinine Clearance (CrCl)\<30 milliliter(mL)/min

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Evaluation of Ketamine and Multi-modal Analgesics | Huxley